Lobbying Filing Details

Total Spending

$2,020,000

Activities

15

Lobbyists

27

Gov't Entities

225

Filing Information
Filing UUID:
6a57e1a3-bc5c-4a45-ac20-c39fad03687a
Type:
3A - 3rd Quarter - Amendment
Period:
2013 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
January 26, 2015 at 9:55 PM
Income:
$0
Expenses:
$2,020,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Brent DelMonte, Vice President for Federal Government Relations
Registrant
BIOTECHNOLOGY INNOVATION ORGANIZATION

Trade Association

Washington, District of Columbia
Client
BIOTECHNOLOGY INNOVATION ORGANIZATION
District of Columbia, United States of America
Lobbying Activities (15)
Activity 1
Agriculture

Livestock Cloning/Product Labeling
Discussions with EU on Animal CloningUSDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
USDA Decision on GE Crops Environmental Impact Statement
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
Amendment on GE Crop Field Trials/Compensation Fund
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)

EPA Regulations on Agricultural Biotechnology
Coordination with USDA on Approvals
Reauthorization and Implementation of Pesticide Registration Improvement Act

Export Registrations for Products with Expired Patents

Fish and Wildlife Service Policy on Planting of Biotech Crops

Labeling of Genetically Engineered Crops
U.S. Government Policy
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014

TransPacific Partnership
Sanitary and Phytosanitary Issues

Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Services, National Institute of Food and Agriculture, APHIS, Trade Activities (Office of the Secretary & Food Safety Inspection Service), National Resources Conservation Service, Agriculture Research Service, Biofuels, Foreign Agriculture Service)
H.R. 2410/S. 1244: Agriculture Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014

Foreign Agricultural Biotechnology Laws and Regulations
Asynchrony of International Approvals
China Biotechnology Regulations
Low-Level Presence Foreign Government Policies

Agricultural Biotechnology Regulatory Reform and Modernization

Benefits of Ag-Biotech Research and Innovation

Biomass Programs
Reauthorization of Biomass Crop Assistance Program
Reauthorization of Biomass R&D Program
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)

Transatlantic Trade and Investment Partnership
Ag-Biotech Issues

Lobbyists (8)
  • MR. BRENT ALAN DELMONTE
  • MATT CARR
  • DAVID EDWARDS
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • CATHLEEN ENRIGHT
  • ERICK LUTT
  • MR. MATTHEW O'MARA
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 2
Animals

Livestock Cloning/Product Labeling
Discussions with EU on Animal CloningGenetically Engineered (GE) Animals
FDA Approval
Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
Amendment on GE Salmon Labeling (Senate)

Lobbyists (4)
  • MR. BRENT ALAN DELMONTE
  • DAVID EDWARDS
  • MR. DANA MAURICE O'BRIEN JR
  • CATHLEEN ENRIGHT
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 3
Budget/Appropriations

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Services, National Institute of Food and Agriculture, APHIS, Trade Activities (Office of the Secretary & Food Safety Inspection Service), National Resources Conservation Service, Agriculture Research Service, Biofuels, Foreign Agriculture Service)
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations for FY 2014

Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure)
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

Funding for Centers for Disease Control and Prevention Vaccine Programs
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

Funding for National Institutes of Health
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

Sequestration of PDUFA Fees
Implementation of S. 365: Budget Control Act
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
HR 2725: Food and Drug Administration Safety Over Sequestration Act of 2013
S. 1413: FDA User Fee Protection Act
H.J. Res 59: Continuing Appropriations Act for FY 2014

Funding for Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014

Funding for Biofuels
Energy and Water Development and Related Agencies Appropriations Act for FY 2014
H.R. 2397: Department of Defense Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

Funding for Biorefineries
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014

Lobbyists (15)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • SARA RADCLIFFE
  • MATT CARR
  • MATTHEW SCHUMAKER
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • RINA SINGH
  • KELLY CAPPIO
  • MS. A. CATHARINE HARRIS
  • ERICK LUTT
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 4
Consumer Issues/Safety/Products

Labeling of Genetically Engineered Crops
U.S. Government Policy
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
USDA Decision on GE Crops Environmental Impact Statement
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
Amendment on GE Crop Field Trials/Compensation Fund
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)

Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning

Genetically Engineered (GE) Animals
FDA Approval
Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
Amendment on GE Salmon Labeling (Senate)

Drug Safety and Review
PDUFA V Implementation
FDA Safety and Innovation Act Implementation
Supply Chain Integrity
Special Medical Use/Limited Population Drugs
Pharmacy Compounding
S. 957: Drug Supply Chain Security Act,
S.959: Pharmaceutical Compounding Quality Act
H.R. 1919: The Safeguarding America Pharmaceuticals Act

Lobbyists (13)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • SARA RADCLIFFE
  • ALAN EISENBERG
  • TOM DILENGE
  • MATTHEW SCHUMAKER
  • MS. ANNA KATHERINE WEINSTEIN
  • DAVID EDWARDS
  • MR. DANA MAURICE O'BRIEN JR
  • CATHLEEN ENRIGHT
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 5
Copyright/Patent/Trademark

Intellectual Property International Enforcement
Compulsory LicensingPatent Reform
Implementation of H.R. 1249: The America Invents Act of 2011
H.R. 2024: End Anonymous Patents Act
H.R. 845: The SHIELD Act of 2013
S. 1013: Patent Abuse Reduction Act of 2013
S. 866: Patent Quality Improvement Act of 2013
House Judiciary Committee Discussion Draft

DNA Patenting and Licensing

TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals

Transatlantic Trade and Investment Partnership
Intellectual Property Issues

Asia Pacific Economic Cooperation Forum
Biologics Regulations

Export Registrations for Products With Expired Patents

Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization

Clinical Trial Data Sharing

Lobbyists (12)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • SARA RADCLIFFE
  • TOM DILENGE
  • HANSJORG SAUER
  • MATTHEW SCHUMAKER
  • MS. ANNA KATHERINE WEINSTEIN
  • JOSEPH DAMOND
  • MR. CHARLES H FRITTS
  • DERRICK M WHITE
  • MR. MATTHEW O'MARA
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 6
Energy/Nuclear

Biorefineries
Reauthorization of Biorefinery Assistance Program
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)Biorefineries Cont...
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014

Biofuels
Accelerated Depreciation Extension
Climate Change Benefits
Production Tax Credit Extension
Renewable Fuel Standard
Implementation
Regulatory Oversight
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 1284: Energy and Water Development and Related Agencies Appropriations Act for FY 2014
H.R. 2397: Department of Defense Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
Expansion of Master Limited Partnerships to Renewable Chemicals
New Production Tax Credit for Renewable Chemicals
Reauthorization of USDA Bio-Preferred Program
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2421: Renewable Chemicals Parity Act
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014

Biomass Programs
Reauthorization of Biomass Crop Assistance Program
Reauthorization of Biomass R&D Program
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)

Lobbyists (7)
  • MR. BRENT ALAN DELMONTE
  • MATT CARR
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • RINA SINGH
  • MR. CHARLES H FRITTS
  • ERICK LUTT
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 7
Food Industry (safety, labeling, etc.)

Livestock Cloning/Product Labeling
Discussions with EU on Animal CloningGenetically Engineered (GE) Animals
FDA Approval
Labeling
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014
Amendment on GE Salmon Labeling (Senate)

Labeling of Genetically Engineered Crops
U.S. Government Policy
S. 1244/H.R. 2410: Agriculture, Rural Development, FDA, and Related Appropriations Act for FY 2014

Lobbyists (5)
  • MR. BRENT ALAN DELMONTE
  • DAVID EDWARDS
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • CATHLEEN ENRIGHT
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 8
Fuel/Gas/Oil

Biorefineries
Reauthorization of Biorefinery Assistance Program
Reauthorization/Funding of Biorefinery Grant and Loan Programs
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)Biorefineries Cont...
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014

Biofuels
Accelerated Depreciation Extension
Climate Change Benefits
Production Tax Credit Extension
Renewable Fuel Standard
Implementation
Regulatory Oversight
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
S. 1284: Energy and Water Development and Related Agencies Appropriations Act for FY 2014
H.R. 2397: Department of Defense Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

Renewable Chemicals/Bio-based Products
Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products
Expansion of Master Limited Partnerships to Renewable Chemicals
New Production Tax Credit for Renewable Chemicals
Reauthorization of USDA Bio-Preferred Program
H.R. 1696/S. 795: Master Limited Partnerships Parity Act
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)
H.R. 2421: Renewable Chemicals Parity Act
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
S. 954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.J. Res 59: Continuing Appropriations Act for FY 2014

Biomass Programs
Reauthorization of Biomass Crop Assistance Program
Reauthorization of Biomass R&D Program
S.954: Agriculture Reform, Food, and Jobs Act of 2013 (Farm Bill)
H.R. 1947: Federal Agriculture Reform and Risk Management Act of 2013 (Farm Bill)

Lobbyists (7)
  • MR. BRENT ALAN DELMONTE
  • MATT CARR
  • TRACEY LATURNER
  • MR. DANA MAURICE O'BRIEN JR
  • RINA SINGH
  • MR. CHARLES H FRITTS
  • ERICK LUTT
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 9
Health Issues

Vaccine Access/Financing
Adult Immunization (Senate Discussion Draft)Biosimilars
Colombia Biologics Regulations
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
Interchangeability and Pharmacy Substitution

Funding for National Institutes of Health
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

Funding for Centers for Disease Control and Prevention Vaccine Programs
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

340B Drug Pricing Program
HRSA Implementation of Program Changes
Implementation of H.R. 3590: (Senate) Patient Protection and Affordable Care Act
S.1284: Department of Labor, HHS, Education, and Related Agencies Appropriations Act of 2014

Expanded Access to Experimental Products
FDA Rules

Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure) (2)
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

Independent Payment Advisory Board
S.351/H.R. 351: Protecting Seniors' Access to Medicare Act of 2013

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

TransPacific Partnership
Data and Intellectual Property Protection for Pharmaceuticals
Regulatory Harmonization

Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
H.R. 1416: Cancer Patient Protection Act of 2013

National Center for Advancing Translational Science (NCATS)
Funding
Program Implementation

Asia Pacific Economic Cooperation Forum
Biologics RegulationTransatlantic Trade and Investment Partnership
Intellectual Property Issues
Regulatory Harmonization

Sequestration of PDUFA Fees
Implementation of S. 365: Budget Control Act
H.R. 2410/S. 1244: Agriculture, Rural Development, FDA, and related agencies Appropriations Act FY 2014
H.R. 2725: Food and Drug Administration Safety Over Sequestration Act of 2013
S. 1413: FDA User Fee Protection Act
H.J. Res 59: Continuing Appropriations Act for FY 2014

Drug Safety and Review
PDUFA V Implementation
FDA Safety and Innovation Act Implementation
Supply Chain Integrity
Special Medical Use/Limited Population Drugs
Pharmacy Compounding
S. 957: Drug Supply Chain Security Act,
S.959: Pharmaceutical Compounding Quality Act
H.R. 1919: The Safeguarding America Pharmaceuticals Act

Orphan Drug Act Issues
Tax Credit

Clinical Trial Data Sharing

Lobbyists (18)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • SARA RADCLIFFE
  • ALAN EISENBERG
  • TOM DILENGE
  • SHELLY MUI-LIPNIK
  • HANSJORG SAUER
  • LAUREL TODD
  • MATTHEW SCHUMAKER
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • KELLY CAPPIO
  • CHARLES CRAIN
  • MS. A. CATHARINE HARRIS
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 10
Homeland Security

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

Lobbyists (9)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • SARA RADCLIFFE
  • MATTHEW SCHUMAKER
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • KELLY CAPPIO
  • DERRICK M WHITE
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 11
Medical/Disease Research/Clinical Labs

Funding for National Institutes of Health
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S. 1284: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2014
H.J. Res 59: Continuing Appropriations Act for FY 2014

National Center for Advancing Translational Science (NCATS)
Funding
Program Implementation

Lobbyists (9)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • MATTHEW SCHUMAKER
  • MS. ANNA KATHERINE WEINSTEIN
  • PHYLLIS ARTHUR
  • TRACEY LATURNER
  • KELLY CAPPIO
  • DERRICK M WHITE
  • MS. ELIZABETH CARTIER ESHAM
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 12
Medicare/Medicaid

Independent Payment Advisory Board
S.351/H.R. 351: Protecting Seniors' Access to Medicare Act of 2013Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
H.R. 1416: Cancer Patient Protection Act of 2013

Lobbyists (5)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • MATTHEW SCHUMAKER
  • MS. A. CATHARINE HARRIS
  • DERRICK M WHITE
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 13
Small Business

Stock Exchange Tick Size
Tick Size Flexibility Act (Rep. Duffy Discussion Draft)
H.R. 1952: The Spread Pricing Liquidity ActSarbanes Oxley Section 404 (b)
Mandatory Audit Firm Rotation
H.R. 1564: The Audit Integrity and Job Protection Act
S. 1526: The Audit Integrity and Job Protection Act

Capital Formation Investment Incentives
Reform of Capital Gains Rules
Reform of Net Operating Loss Rules
Reform of Passive Loss Rules
H.R. 6559/S.3595: High Technology Small Business Research Incentives Act

Reform of SEC Regulation D
Implementation of Jumpstart Our Business Start-ups (JOBS) Act

Expansion of Exemption Under SEC Regulation A
H.R. 701: To amend a provision of the Securities Act of 1933 directing the Securities and Exchange Commission to
add a particular class of securities to those exempted under such Act to provide a deadline
for such action
Rep. McHenry Discussion Draft

Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions
H.R. 2629: Fostering Innovation Act

Market Structure Reform for Small Companies
XBRL Exemption for Small Public Companies

Lobbyists (7)
  • MR. BRENT ALAN DELMONTE
  • ALAN EISENBERG
  • TOM DILENGE
  • SHELLY MUI-LIPNIK
  • CHARLES CRAIN
  • MR. CHARLES H FRITTS
  • DERRICK M WHITE
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 14
Taxation/Internal Revenue Code

Biofuels
Production Tax Credit Extension
Accelerated Depreciation ExtensionRenewable Chemicals/Bio-based Products
Expansion of Master Limited Partnerships to Renewable Chemicals
New Production Tax Credit for Renewable Chemicals
S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act
H.R. 1696/S. 795: Master Limited Partnerships Parity Act


Research & Development Tax Credit Reforms
Startup Innovation Credit (Senator Coons Discussion Draft)
Innovative Research and Competitiveness Act (Senator Carper Discussion Draft)
H.R.119: To amend the Internal Revenue Code to make permanent the credit for increasing research activities

Capital Formation Investment Incentives
Reform of Capital Gains Rules
Reform of Net Operating Loss Rules
Reform of Passive Loss Rules
H.R. 6559/S.3595: High Technology Small Business Research Incentives Act

Tax Reform

Orphan Drug Act Issues
Tax Credit

Lobbyists (13)
  • MR. BRENT ALAN DELMONTE
  • ALAN EISENBERG
  • TOM DILENGE
  • SHELLY MUI-LIPNIK
  • MATT CARR
  • MATTHEW SCHUMAKER
  • MS. ANNA KATHERINE WEINSTEIN
  • MR. DANA MAURICE O'BRIEN JR
  • RINA SINGH
  • CHARLES CRAIN
  • MR. CHARLES H FRITTS
  • ERICK LUTT
  • DERRICK M WHITE
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more
Activity 15
Trade (domestic/foreign)

Livestock Cloning/Product Labeling
Discussions with EU on Animal CloningIntellectual Property International Enforcement
Compulsory Licensing

Foreign Agricultural Biotechnology Laws and Regulations
Asynchrony of International Approvals
China Biotechnology Regulations
Low-Level Presence Foreign Government Policies

TransPacific Partnership
Data and Intellectual Property Protection for Pharmaceuticals
Intellectual Property Issues
Regulatory Transparency

Transatlantic Trade and Investment Partnership
Ag-Biotech Issues
Intellectual Property Issues
Regulatory Harmonization

Asia Pacific Economic Cooperation Forum
Biologics Regulations

Biosimilars
Colombia Biologics Regulations

Genetic Resource Patent Disclosure Requirement
World Intellectual Property Organization

Clinical Trial Data Sharing

Lobbyists (11)
  • MR. BRENT ALAN DELMONTE
  • JEANNE HAGGERTY
  • ANDREW EMMETT
  • SARA RADCLIFFE
  • TOM DILENGE
  • HANSJORG SAUER
  • DAVID EDWARDS
  • JOSEPH DAMOND
  • CATHLEEN ENRIGHT
  • MR. CHARLES H FRITTS
  • MR. MATTHEW O'MARA
Government Entities (15)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of Science & Technology Policy (OSTP)
  • ... and 10 more

Source: LDA.gov, data retrieved November 5, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.